Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
Authors
Keywords
-
Journal
Journal of Cachexia Sarcopenia and Muscle
Volume 7, Issue 5, Pages 567-576
Publisher
Wiley
Online
2016-04-13
DOI
10.1002/jcsm.12115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer
- (2015) Yuji Miyamoto et al. ANNALS OF SURGICAL ONCOLOGY
- Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer
- (2015) B.H.L. Tan et al. EJSO
- Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer
- (2015) Bjørg Sjøblom et al. LUNG CANCER
- Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012
- (2015) Kyu-Won Jung et al. Cancer Research and Treatment
- Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015
- (2015) Stephan von Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer-specific and all-cause mortality
- (2014) Sarah P. Psutka et al. CANCER
- Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
- (2014) Vincent Camus et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy
- (2014) Hee-Won Jung et al. SUPPORTIVE CARE IN CANCER
- An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
- (2013) Z. Zhou et al. BLOOD
- Clinical outcomes related to muscle mass in humans with cancer and catabolic illnesses
- (2013) Vickie Baracos et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
- (2013) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
- (2013) Hélène Lanic et al. LEUKEMIA & LYMPHOMA
- The Relationship Between Body Composition and Response to Neoadjuvant Chemotherapy in Women with Operable Breast Cancer
- (2012) E. Del Fabbro et al. ONCOLOGIST
- Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
- (2012) Olivier Mir et al. PLoS One
- Worsening Central Sarcopenia and Increasing Intra-Abdominal Fat Correlate with Decreased Survival in Patients with Adrenocortical Carcinoma
- (2012) Barbra S. Miller et al. WORLD JOURNAL OF SURGERY
- CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
- (2011) Michael Pfreundschuh et al. LANCET ONCOLOGY
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
- (2010) S. Antoun et al. ANNALS OF ONCOLOGY
- An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity
- (2010) Carla M. M. Prado et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
- (2009) B. H.L. Tan et al. CLINICAL CANCER RESEARCH
- Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
- (2009) C. M.M. Prado et al. CLINICAL CANCER RESEARCH
- How To Build and Interpret a Nomogram for Cancer Prognosis
- (2008) Alexia Iasonos et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started